Epithelial—mesenchymal and mesenchymal—epithelial transitions in carcinoma progression
Tóm tắt
Like a set of bookends, cellular, molecular, and genetic changes of the beginnings of life mirror those of one of the most common cause of death—metastatic cancer. Epithelial to mesenchymal transition (EMT) is an important change in cell phenotype which allows the escape of epithelial cells from the structural constraints imposed by tissue architecture, and was first recognized by Elizabeth Hay in the early to mid 1980's to be a central process in early embryonic morphogenesis. Reversals of these changes, termed mesenchymal to epithelial transitions (METs), also occur and are important in tissue construction in normal development. Over the last decade, evidence has mounted for EMT as the means through which solid tissue epithelial cancers invade and metastasize. However, demonstrating this potentially rapid and transient process in vivo has proven difficult and data connecting the relevance of this process to tumor progression is still somewhat limited and controversial. Evidence for an important role of MET in the development of clinically overt metastases is starting to accumulate, and model systems have been developed. This review details recent advances in the knowledge of EMT as it occurs in breast development and carcinoma and prostate cancer progression, and highlights the role that MET plays in cancer metastasis. Finally, perspectives from a clinical and translational viewpoint are discussed. J. Cell. Physiol. 213: 374–383, 2007. © 2007 Wiley‐Liss, Inc.
Từ khóa
Tài liệu tham khảo
Deyrup AT, 2007, Epithelioid and epithelial neoplasms of bone, Arch Pathol Lab Med, 131, 205, 10.5858/2007-131-205-EAENOB
Gao X, 2007, Quantum dots for in vivo molecular and cellular imaging, Methods Mol Biol, 374, 135
Ishikawa S, 1979, Ultrastructure of mesodermal mixed tumor of the uterus, Acta Pathol Jpn, 29, 801
Kokinnos M, 2007, Vimentin and epithelial‐to‐mesenchymal transition in human breast cancer—observations in vitro and in vivo, Cells Tissues Organs, 185
Lebret SC, 2006, Myoepithelial molecular markers in human breast carcinoma PMC42‐LA cells are induced by extracellular matrix and stromal cells, In Vitro Cell Dev Biol Anim, 42, 298
Monaghan P, 1985, An immunocytochemical and ultrastructural study of heterogeneity in the human breast carcinoma cell line P MC42, Cancer Res, 45, 5088
Saegusa M, 2007, A functional role of Cdx2 in {beta}‐catenin signaling during trans‐differentiation in endometrial carcinomas, Carcinogenesis Apr 29 [Epub ahead of print].
Sommers CL, 1992, Loss of epithelial markers and acquisition of vimentin expression in adriamycin‐ and vinblastine‐resistant human breast cancer cell lines, Cancer Res, 52, 5190
Tomita K, 2000, Cadherin switching in human prostate cancer progression, Cancer Res, 60, 3650
Whitehead RH, 1983, A new human breast carcinoma cell line (PMC42) with stem cell characteristics. I. Morphologic characterization, J Natl Cancer Inst, 70, 649
Whitehead RH, 1983, A new human breast carcinoma cell line (PMC42) with stem cell characteristics. II. Characterization of cells growing as organoids, J Natl Cancer Inst, 71, 1193
Whitehead RH, 1984, A new human breast carcinoma cell line (PMC42) with stem cell characteristics. III. Hormone receptor status and responsiveness, J Natl Cancer Inst, 73, 643
Xue C, 2003, The gatekeeper effect of epithelial‐mesenchymal transition regulates the frequency of breast cancer metastasis, Cancer Res, 63, 3386
Zajchowski DA, 2001, Identification of gene expression profiles that predict the aggressive behavior of breast cancer cells, Cancer Res, 61, 5168